Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication

Lonneke van der Linden1, Hilde M van der Schaar, Kjerstin H W Lanke

  • 1Department of Medical Microbiology, Nijmegen Centre for Molecular Life Sciences and Nijmegen Institute for Infection, Inflammation and Immunity, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands.

Journal of Virology
|May 28, 2010
PubMed

Insights

Golgicide A (GCA) inhibits enterovirus replication by targeting Golgi-specific BFA resistance factor 1 (GBF1). Unlike AG1478, GCA suppresses viral RNA replication, making it a potential tool for studying enteroviruses.

Area of Science:

  • Virology
  • Cell Biology
  • Drug Discovery

Background:

  • Enteroviruses, including poliovirus and coxsackievirus, are significant human pathogens.
  • Brefeldin A (BFA) inhibits enterovirus replication by targeting Golgi-specific BFA resistance factor 1 (GBF1), crucial for secretory pathway function.
  • GBF1 regulates Arf1 GTP exchange, influencing coatomer protein complex I (COP-I) recruitment for vesicle transport.

Purpose of the Study:

  • To investigate the effects of novel GBF1 inhibitors, AG1478 and Golgicide A (GCA), on secretory pathway function and enterovirus replication.
  • To elucidate the molecular mechanisms by which AG1478 and GCA affect GBF1 and viral replication.

Main Methods:

  • Treatment of cells with AG1478 and GCA to assess effects on Golgi vesicles, Arf1, and COP-I localization.
  • Overexpression of Arf1 and GBF1 to determine rescue effects on drug-induced inhibition.
  • Analysis of coxsackievirus B3 (CVB3) replication and RNA synthesis using time-of-addition studies and subgenomic replicons.

Main Results:

  • Both AG1478 and GCA induced Golgi vesicle fragmentation and dissociation of Arf1/COP-I from Golgi membranes.
  • GCA, but not AG1478, significantly reduced CVB3 and other enterovirus replication.
  • GCA suppressed CVB3 RNA replication, an effect reversible by GBF1 overexpression, indicating direct targeting of GBF1.

Conclusions:

  • Golgicide A (GCA) directly inhibits enterovirus RNA replication by targeting GBF1, unlike AG1478.
  • AG1478 and GCA represent valuable pharmacological tools for dissecting enterovirus replication mechanisms.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...